Important contacts for the stroke team
The management of acute stroke is divided into the following areas: 1) Hyperacute management including stroke thrombolysis.
2) Physiological support in the first 24 -48 hours (salvage of peri-infarct tissue at risk of infarction: the ischaemic penumbra). 3) Prevention and management of complications (medical or neurological). 4) Early secondary prevention. 5) Early rehabilitation.
Hyperacute Management
Any person with acute onset neurological symptoms and signs needs rapid diagnosis to differentiate between acute cerebrovascular cause and others, such as hypoglycaemia or head injury (see Guideline 145 Evaluation and Investigation of Acute Stroke).
All patients should be transferred to the Hyperacute Stroke Unit (HASU) once assessed and stabilised, unless there are extenuating circumstances and the case has been discussed with the SPOC.
Brain imaging
Should be performed immediately (ideally next slot or within one hour) in the following cases:
 Indication for thrombolysis (will need an immediate scan) or early anticoagulation.  On anticoagulant therapy (warfarin or new oral anticoagulants such as dabigatran).  Known bleeding tendency.  Depressed level of consciousness (GCS <13).  Unexplained fluctuating neurological symptoms.  Papillodema, neck stiffness or fever.  Severe headache at onset of symptoms.
All people with acute stroke should have brain imaging within 12 hours of admission (RCP Guidelines, 2012).
Brain imaging is necessary to delineate the type of vascular event, as the management is dependent on the aetiology.
Acute ischaemic stroke
Consideration should be made for acute thrombolytic therapy.
THROMBOLYSIS (see also Guideline 149A Acute Stroke Admission Pathway for inclusion/exclusion criteria, dosage and monitoring guidelines).
 Thrombolysis if given within 4.5 hours of acute ischaemic stroke improves outcome.
 All patients admitted within 4.5 hours of stroke onset or with in-hospital stroke, should be referred immediately to the SNOD before arranging any investigations.
 The stroke nurse will organise urgent brain imaging, CT or MRI and inform the SPOC.  After brain imaging the stroke physician will advise to start alteplase, if appropriate.
 Check blood glucose, insert an IV line and perform an ECG after contacting the stroke nurse.
 Out of working hours the stroke physician will be available to review the patient via telemedicine. The medical registrar on-call should assess the patient and assist the stroke physician in the neurological assessment.
 The medical registrar will be expected to do the NIHSS scoring and record it in the patient notes. Any patient, regardless of age or stroke severity, where treatment can be started within 4.5 hours of known symptom onset and who has been shown not to have an intracerebral haemorrhage or other contraindications, should be considered for treatment using alteplase.


Intracerebral haemorrhage (ICH)
 Anticoagulation with warfarin should be reversed immediately using both prothrombin complex concentrate and intravenous vitamin K (discuss with haematologist). o Intracerebral haemorrhage secondary to a cerebral aneurysm.
Physiological Support
There is very strong evidence that Stroke Unit care reduces mortality and morbidity in patients with acute stroke. Patients suspected of having acute stroke should be transferred to the HASU within 4 hours of their admission to the CSRU.
Hypertension
In general, any pre-existing antihypertensive medication should continue to be given, assuming the patient can swallow and take their medication. If the patient is unable to swallow, consult the ward pharmacist for advice.
Antihypertensive treatment in acute stroke is recommended if there is one or more of the following:  Hypertensive encephalopathy.  Hypertensive nephropathy.
 Hypertensive cardiac failure.  Aortic dissection.  Pre-eclampsia/eclampsia.  Intracerebral haemorrhage with systolic blood pressure over 180 mmHg (see above).
Acutely elevated BP is common following ischaemic stroke and should not be treated aggressively.
In patients with a systolic BP >220 mmHg, or a diastolic BP >110 mmHg, blood pressure should be reduced gradually.
Candidates for intravenous thrombolysis should be considered for blood pressure reduction if blood pressure is above 185/110 mmHg. This can be achieved using intravenous labetalol.
If using labetalol intravenously, give 10 -20 mg over 1 -2 minutes. An alternative is intravenous glyceryl trinitrate infusion 0.5 -10 mg per hour. For oral therapy consider ramipril 2.5 mg or amlodipine 5 mg.
Hypotension
If the blood pressure is below 140 mmHg systolic then omit normal antihypertensives and correct hypovolaemia with intravenous sodium chloride 0.9%. Consider a cause of hypotension, e.g. cardiac ischaemia, arrhythmia or sepsis.
Fever
Treat hyperthermia (temperature >37.5°C) with paracetamol (1 g four times daily PO/IV) and cooling (fans, sponging).
Identify and treat any infection following the guidelines given on the Antimicrobial Sector of RxGuidelines (see https://viewer.rx-guidelines.com/bucks).
Glucose
If the blood glucose remains >10 mmol/L, consider starting an insulin sliding scale, as high blood glucose can worsen the ischaemic damage.
Oxygen
Give oxygen (24%) to patients with O 2 saturations persistently below 95%.
Cardiac arrhythmia
All patients should have continuous cardiac monitoring for the first 48 hours on the HASU.
Fluids and electrolytes
Correct hypovolaemia and then give maintenance fluids. Almost all acute stroke patients need intravenous fluid therapy. Consider using intravenous sodium chloride 0.9% for fluid replacement. Avoid glucose if possible (unless hyperosmolar, hypoglycaemic or on an insulin sliding scale).
Prevention and Management of Complications
Much of the mortality and morbidity following stroke is from secondary complications.
Swallowing
All patients with acute stroke should be screened for a swallowing disorder before being given oral food/fluids. This should be done by a person with specific training in swallowing disorders using the pathway in Guideline 149A Acute Stroke Admission Pathway.
Nutrition
All patients should be screened for malnutrition using the Malnutrition Universal Screening Tool (MUST). Consideration should be made for a nasogastric tube within the first 24 hours if the patient is not eating orally. Uncontrolled if printed
Venous thromboembolism
First line thromboembolism prophylaxis in patients with acute stroke is with intermittent pneumatic compression (IPC) boots -see Mandatory Risk Assessment for Venous Thromboembolism (VTE) for Stroke ICP (Guidelines 765 and 733FM, Appendix 5.2).
DVT prophylaxis using heparin or graduated support stockings should NOT be used routinely.
Urinary catheters
Catheters should be avoided where possible. Incontinence is not an appropriate indication for urinary catheterisation. Appropriate indications for urinary catheterisation are:
 Urinary retention.  Need for accurate fluid balance.  Sacral pressure area.  Dignity in end of life care.
Pressure areas
Pressure areas should be prevented by risk assessment (e.g. Waterlow), pressure-relieving mattresses where appropriate, regular inspection and attention to nutrition.
Cerebral oedema
This tends to peak at 3 -5 days after cerebral infarction.
Patients with space-occupying cerebellar infarction and reduced conscious level should be discussed with neurosurgery for consideration of urgent decompressive surgery.
In selected patients with space-occupying supra-tentorial infarction (malignant middle cerebral artery syndrome), consider referral for urgent hemicraniectomy (surgical decompression). This should be done after discussion with the SPOC. Suitable patients will be relatively young, have large MCA territory strokes and have drowsiness. Referrals are made in the first instance to the John Radcliffe Stroke Unit on-call team. If suitable, patients are transferred to the Stroke Unit at the John Radcliffe (ward 5B) where they will be reviewed by the neurosurgeons. Referrals should be made within 24 hours of stroke onset and surgery should occur within 48 hours of stroke onset.
Hydrocephalus
Consider if there is neurological deterioration, especially if there has been intraventricular haemorrhage or if there has been posterior fossa stroke (e.g. cerebellar bleed or infarction). Urgent ventriculostomy may be required.
Seizures
Common especially after cerebral haemorrhage. Consider in any deterioration and treat conventionally, e.g. with diazepam 10 mg IV or lorazepam 4 mg IV, followed by a phenytoin infusion. Phenytoin should be given as an infusion of 20 mg/kg at a rate not exceeding 50 mg/minute. A maintenance dose of 100 mg six to eight hourly orally or intravenously is then given. Prepare the initial infusion using the Buckinghamshire Healthcare NHS Trust Injectables Guide. See also Guideline 73 Phenytoin Information for Prescribing, Monitoring and Administration in Adults.
anticoagulation in most cases, unless the patient requires long term treatment with both anticoagulation and antiplatelet treatment.
 Treatment with fractionated or unfractionated heparin should be reserved for highly selected cases and should be undertaken only after discussion with the SPOC. There is a significant risk of haemorrhagic conversion of cerebral infarction with the use of therapeutic doses of heparin or low molecular weight heparin.
Blood pressure
Blood pressure reduction after stroke prevents further vascular events. Treatment should be initiated or increased to achieve a blood pressure below 130/80 except in severe bilateral carotid stenosis when the target is 130 -150 systolic.
The blood pressure often falls spontaneously over the first few days after stroke, so blood pressure lowering therapy for long term secondary prevention should be initiated at hospital discharge or at 1 -2 weeks, whichever is later.
If target BP not achieved, refer to specialist.
Agent of choice:
 Over 55 years or AfroCaribbean of any age: Long acting dihydropiridine calcium channel blocker (e.g. amlodipine) or, if not tolerated or there is evidence of (or a high risk of) heart failure, give a thiazide diuretic, e.g. indapamide.
If not achieved add ACE-I (e.g. ramipril) or ARB (e.g. candesartan)
 Under 55 years ACE-I or ARB See Guideline 227FM Management of Hypertension in Adults.
Lipids
All patients with non-cardioembolic ischaemic stroke or TIA should be offered treatment with a statin unless contraindicated. Patients with cardioembolic stroke may be offered a statin, particularly if there is evidence of atherosclerosis -see Guideline 104FM Statins and Ezetimibe for the Primary and Secondary Prevention of Cardiovascular Disease) for recommendations on which statin to use. Statin therapy should not be given routinely in primary intracerebral haemorrhage, as there is an association between statin use and cerebral haemorrhage. Statins may nevertheless be appropriate if the risk of vascular events due to atherosclerosis is very high.
Carotid stenosis
Any patient with a carotid artery territory TIA or stroke without severe disability should be considered for endarterectomy.
Carotid imaging should be organised, either MRA, duplex scan or CTA.
Endarterectomy should be considered in symptomatic stenosis of 50 -99% using the NASCET criteria (symptomatic stenosis 70 -99% using ECST criteria).
Surgery should be performed within two weeks of symptoms and preferably within one week.
Lifestyle modifications
 Advise to stop smoking and support with formal smoking cessation programme.  Advise to take regular exercise.  Eat an optimum diet.  Reduce saturated fats.  Reduce salt intake.  Alcohol should be kept within recognised safe drinking limits.
